2021
DOI: 10.7150/ijbs.53657
|View full text |Cite
|
Sign up to set email alerts
|

CD151 promotes Colorectal Cancer progression by a crosstalk involving CEACAM6, LGR5 and Wnt signaling via TGFβ1

Abstract: CD151 impacts various signaling pathways in different cancers, and promotes colorectal cancer (CRC) cell malignancy by yet undefined mechanisms. This study aimed to comprehensively assess CD151's function in CRC. CD151 levels were significantly higher in CRC tissues and cells compared with controls in the tissue microarray. Cell viability, migration and invasion were suppressed by CD151 downregulation in CRC cells. Consistently, mouse xenografts were inhibited by CD151 silencing. RNA-seq revealed that multiple… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

2
8
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 11 publications
(11 citation statements)
references
References 35 publications
2
8
0
Order By: Relevance
“…CEACAM6 is a human tumor marker found in excess in colon tumors. Moreover, B2 phylogroup E. coli strains associated with Crohn’s disease intensify the expression of CEACAM6 receptors in gut epithelial cells ( Jantscheff et al., 2003 ; Ferlizza et al., 2020 ; Yang et al., 2021 ). Most AIEC isolates belong to phylogroups B2 (54.2%) and D (29.2%).…”
Section: Discussionmentioning
confidence: 99%
“…CEACAM6 is a human tumor marker found in excess in colon tumors. Moreover, B2 phylogroup E. coli strains associated with Crohn’s disease intensify the expression of CEACAM6 receptors in gut epithelial cells ( Jantscheff et al., 2003 ; Ferlizza et al., 2020 ; Yang et al., 2021 ). Most AIEC isolates belong to phylogroups B2 (54.2%) and D (29.2%).…”
Section: Discussionmentioning
confidence: 99%
“…Many pathways are associated with the pathogenesis of CD. Signaling pathway include immune system [69], neutrophil degranulation [114], GDF15 [115], IL1RN [116] STAT1 [117], SLAMF7 [105], CYP27B1 [118], NETO2 [119], TFPI2 [120], ZC3H12A [121], MMP1 [122], CSF3 [123], SOCS3 [124], TLR8 [125], HTRA3 [126], CEBPB (CCAAT enhancer binding protein beta) [127], CD55 [128], CXCR2 [129], CCL28 [130], CBR3 [131], CCL3 [132], FCGR2A [48], ACSL1 [133], CCL2 [134], SOD2 [135] [150], CCR2 [151], VWF (von Willebrand factor) [152], SLC7A11 [153], NOD2 [154], DMBT1 [155], IL20RA [156], TYMP (thymidine phosphorylase) [144], S100P [157], PDPN (podoplanin) [158], ADAMTS1 [159], ATF3 [160], TIMP1 [161], UCN2 [162], SELE (selectin E) [163], ICAM1 [164], FOSL1 [165], AREG (amphiregulin) [166], PIM2 [167], SLC7A5 [168], CH25H [169], COL5A2 [170], SNAI1 [171], MXRA5 [172], EGR1 [173], TNFRSF17 [174], MDFI (MyoD family inhibitor) [175], SRGN (serglycin) [176], CEACAM6 [177], CCL11…”
Section: Discussionmentioning
confidence: 99%
“…Many pathways are associated with the pathogenesis of CD. [124], TLR8 [125], HTRA3 [126], CEBPB (CCAAT enhancer binding protein beta) [127], CD55 [128], CXCR2 [129], CCL28 [130], CBR3 [131], CCL3 [132], FCGR2A [48], ACSL1 [133], CCL2 [134], SOD2 [135], CD14 [136], IGFBP2 [137], CD274 [138], DERL3 [139], SERPINE1 [140], IDO1 [141], PDK1 [142] [156], TYMP (thymidine phosphorylase) [144], S100P [157], PDPN (podoplanin) [158], ADAMTS1 [159], ATF3 [160], TIMP1 [161], UCN2 [162], SELE (selectin E) [163], ICAM1 [164], FOSL1 [165], AREG (amphiregulin) [166], PIM2 [167], SLC7A5 [168], CH25H [169], COL5A2 [170], SNAI1 [171], MXRA5 [172], EGR1 [173], TNFRSF17 [174], MDFI (MyoD family inhibitor) [175], SRGN (serglycin) [176], CEACAM6 [177], CCL11 [178], IFNG (interferon gamma) [179], TREM2 [180], INHBA (inhibin subunit beta A) [181], APOE (apolipoprotein E) [182], FGR (FGR proto-oncogene, Src family tyrosine kinase) GBP5 [465], HGF (hepatocyte growth factor) [466], CXCL9 [467], SLC11A1 [468], IL1RN [469], STAT1 [470], CYP27B1 [471], MMP1 [472], SOCS3 [473], TLR8 [474], CD55 [475], CCL28 [476], FCGR2A [477], CCL2 [478],...…”
Section: Discussionmentioning
confidence: 99%
“…Human HT29 and HCT116 cell lines were grown in McCoy’s 5A media (Gibco, CA, USA) containing 10% FBS and penicillin/streptomycin at 37°C in a 5% CO₂ incubator ( Yang et al, 2021 ).…”
Section: Methodsmentioning
confidence: 99%
“…Primers used for qPCR are compiled in Supplementary Table S1 . A Real-Time PCR system (BIOER Co. Ltd., Kokyo, Japan) was used for all qPCR analyses, and the relative expression of CLDN11, CLDN4, and TGFβ1 was assessed via the ΔCT method as in prior reports ( Yang et al, 2021 ). For appropriate experiments, the HT29 and HCT116 cells were treated for 48 h with the TGFβ1 inhibitor LY364947 (5.00 or 10.0uM).…”
Section: Methodsmentioning
confidence: 99%